Abstract
Defensins are a family of antimicrobial cationic peptides that act as a rapid response force against microbial invasion in a wide range of organisms, including plants, insects, animals and humans. In humans, defensins are produced predominantly by leukocytes and epithelial cells and are an important factor of innate immunity. In addition to their major role as natural antibiotics, defensins are increasingly recognized as signaling molecules in adaptive immunity and aberrant defensin expression has been associated with infectious diseases. In this review, we discuss the role of human defensins in relation to infectious disease and the possibility of novel defensin-based therapeutic approaches.
Keywords: Defensins, infectious disease, therapeutics
Infectious Disorders - Drug Targets
Title: Human Defensins: Turning Defense into Offense?
Volume: 7 Issue: 1
Author(s): Erik de Leeuw and Wuyuan Lu
Affiliation:
Keywords: Defensins, infectious disease, therapeutics
Abstract: Defensins are a family of antimicrobial cationic peptides that act as a rapid response force against microbial invasion in a wide range of organisms, including plants, insects, animals and humans. In humans, defensins are produced predominantly by leukocytes and epithelial cells and are an important factor of innate immunity. In addition to their major role as natural antibiotics, defensins are increasingly recognized as signaling molecules in adaptive immunity and aberrant defensin expression has been associated with infectious diseases. In this review, we discuss the role of human defensins in relation to infectious disease and the possibility of novel defensin-based therapeutic approaches.
Export Options
About this article
Cite this article as:
de Leeuw Erik and Lu Wuyuan, Human Defensins: Turning Defense into Offense?, Infectious Disorders - Drug Targets 2007; 7 (1) . https://dx.doi.org/10.2174/187152607780090702
DOI https://dx.doi.org/10.2174/187152607780090702 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Natural Products in the Ligand Deorphanization of TRP Channels
Current Pharmaceutical Design Modifications of the Immune Responsiveness in Patients with Autoimmune Thyroiditis: Evidence for a Systemic Immune Alteration
Current Pharmaceutical Design Phytochemical Screening, Alpha-Glucosidase Inhibition, Antibacterial and Antioxidant Potential of Ajuga bracteosa Extracts
Current Pharmaceutical Biotechnology Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies
Current Drug Targets Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Expiratory High-Resolution CT in Diffuse Lung Diseases
Current Respiratory Medicine Reviews Clinical Signs, Prevention and Treatment of Viral Infections in Infants
Infectious Disorders - Drug Targets Tetrandrine for Targeting Therapy Resistance in Cancer
Current Topics in Medicinal Chemistry From Stem Cell Biology to The Treatment of Lung Diseases
Current Stem Cell Research & Therapy New Treatments for COPD in the Elderly
Current Pharmaceutical Design Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets New Oxazolidines Inhibit the Secretion of IFN-γ and IL-17 by PBMCS from Moderate to Severe Asthmatic Patients
Medicinal Chemistry New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry Allergen-like Molecules from Parasites
Current Protein & Peptide Science Inhalational Anesthetics in Acute Severe Asthma
Current Drug Targets Biologics for ANCA-Associated Vasculitis
Inflammation & Allergy - Drug Targets (Discontinued) Polymeric Carrier Systems for siRNA Delivery
Current Topics in Medicinal Chemistry NLRP3 Is Involved in Ischemia/Reperfusion Injury
CNS & Neurological Disorders - Drug Targets From Early Origins. When and Why does Asthma Develop?
Current Pediatric Reviews Characterization of β-Sitosterol for Potential Selective GR Modulation
Protein & Peptide Letters